Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / CFTR / GlyH-101

GlyH-101 {[allProObj[0].p_purity_real_show]}

货号:A128948 同义名: CFTR Inhibitor II; Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor II

GlyH-101是一种甘氨基氮化合物,是一种可逆的电压依赖性CFTR氯离子通道阻滞剂,Ki为4.3 μM。

GlyH-101 化学结构 CAS号:328541-79-3
GlyH-101 化学结构
CAS号:328541-79-3
GlyH-101 3D分子结构
CAS号:328541-79-3
GlyH-101 化学结构 CAS号:328541-79-3
GlyH-101 3D分子结构 CAS号:328541-79-3
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

GlyH-101 纯度/质量文件 产品仅供科研

货号:A128948 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 CFTR 其他靶点 纯度
Ataluren 98%
Lumacaftor ++++

F508del-CFTR, EC50: 0.1 μM

98%
CFTR(inh)-172 +++

CFTR, Ki: 300 nM

99%+
GlyH-101 +

CFTR, Ki: 4.3 μM

99%+
IOWH-032 ++

CFTR, IC50: 1.01 μM

99%+
Tezacaftor 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

GlyH-101 生物活性

靶点
  • CFTR

    CFTR, Ki:4.3 μM

描述 The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a cAMP-activated epithelial Cl- channel. GlyH-101 is a glycine hydrazide compound that inhibits CFTR with a Ki value of 4.3±0.9μM. The inhibitory potency of GlyH-101 against CFTR was reduced at more negative voltages, with Ki values of 1.4, 3.8, 5.0, and 5.6μM for voltages of +60, +20, −20, and −60mV, respectively.[3] GlyH-101 inhibited cAMP/PKA-activated Cl- current in a dose- and voltage-dependent manner with IC50 values of 0.3±1.5 and 5.1±1.3μM at +100 and −100mV, respectively.[4] GlyH-101 at a dosage of 10μM rapidly and reversibly inhibited forskolin-induced hyperpolarization in nasal potential differences in mice (CD1 strain).[3]
作用机制 The inhibition of CFTR by GlyH-101 involves direct CFTR pore occlusion at a site at or near the extracellular-facing pore surface.[3]

GlyH-101 细胞实验

Cell Line
Concentration Treated Time Description References
Rat pancreatic explants 10 μmol/l 1-7 days GlyH-101 increased the absolute number of NGN3+ endocrine progenitors and the number of beta cells, as well as the expression of insulin and Mafa. Diabetologia. 2013 Feb;56(2):330-9.
Murine renal proximal convoluted tubule cells (PCT) 10 µM GlyH-101 blocked more than 70% of the CaCC conductance at 10 µM. Br J Pharmacol. 2014 Aug;171(15):3716-27.
PS120 cells (non-CFTR expressing) 0.5, 1, 5, 10 µM GlyH-101 significantly inhibited VSORC currents with IC50 values of approximately 5.38 µM (negative potentials) and 6.26 µM (positive potentials). Br J Pharmacol. 2014 Aug;171(15):3716-27.
Murine renal distal convoluted tubule cells (DCT) 0.5, 1, 5, 10 µM GlyH-101 induced a concentration-dependent inhibition of the CFTR-like current, with almost complete inhibition at 10 µM and a more pronounced effect at positive potentials. Br J Pharmacol. 2014 Aug;171(15):3716-27.
Mouse beta-cells 50 μM 10 minutes To investigate the effect of GlyH-101 on cAMP-enhanced insulin secretion, results showed that GlyH-101 significantly inhibited cAMP-enhanced insulin secretion. BMC Med. 2014 May 28;12:87.
Human beta-cells 50 μM 10 minutes To investigate the effect of GlyH-101 on cAMP-enhanced insulin secretion, results showed that GlyH-101 significantly inhibited cAMP-enhanced insulin secretion. BMC Med. 2014 May 28;12:87.
Calu-3KD cells 50 μM 30 minutes GlyH-101 partially inhibited CFTR channel activity in Calu-3KD cells, but responses to lubiprostone and CCh were retained. Br J Pharmacol. 2007 Apr;150(8):1055-65.
Calu-3WT cells 50 μM 30 minutes GlyH-101 completely inhibited CFTR channel activity in Calu-3WT cells, resulting in no response to lubiprostone or CCh. Br J Pharmacol. 2007 Apr;150(8):1055-65.
Human airway smooth-muscle cells 2 μM 5 hours To evaluate the effects of GlyH-101 on cellular sphingolipid composition. Results showed GlyH-101 increased sphinganine and dihydroceramides. Am J Respir Cell Mol Biol. 2020 Nov;63(5):690-698.
Human alveolar epithelial cell line A549 2 μM 5 hours To evaluate the effects of GlyH-101 on cellular sphingolipid composition. Results showed GlyH-101 increased sphinganine and dihydroceramides. Am J Respir Cell Mol Biol. 2020 Nov;63(5):690-698.
Calu-3 cells 10 μM GlyH-101 had no effect on the mean alkalinization produced by the removal of basolateral Cl- under non-stimulated conditions, but in the presence of GlyH-101, the cAMP agonist forskolin failed to fully inhibit the basolateral exchanger Br J Pharmacol. 2013 Apr;168(8):1946-60.
Normal Human Bronchial Epithelial cells (NHBE) 10 μM 20-50 minutes GlyH-101 significantly blocked H2O2-induced CFTR-dependent current changes Am J Respir Cell Mol Biol. 2013 Oct;49(4):672-9.

GlyH-101 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice Pregnant E12.5 mice Subcutaneous injection 10 mg/kg Twice daily for six consecutive days GlyH-101 increased the surface area of insulin+ and glucagon+ cells in E18.5 pancreases but did not modify beta cell proliferation. Diabetologia. 2013 Feb;56(2):330-9.
Mice SPT-deficient mice Intratracheal administration 80 mg/kg Single dose, evaluated after 4 hours To evaluate the effects of GlyH-101 on airway hyperreactivity. Results showed GlyH-101 decreased AHR in SPT-deficient mice. Am J Respir Cell Mol Biol. 2020 Nov;63(5):690-698.

GlyH-101 参考文献

[1]Mutyam V, Libby EF, et al. Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation. J Cyst Fibros. 2017 Jan;16(1):24-29.

[2]Hadida S, Van Goor F,et al. Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide(VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator. J Med Chem. 2014 Dec 11;57(23):9776-95.

[3]Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol. 2004;124(2):125-137. doi:10.1085/jgp.200409059

[4]Barman PP, Choisy SC, Gadeberg HC, Hancox JC, James AF. Cardiac ion channel current modulation by the CFTR inhibitor GlyH-101. Biochem Biophys Res Commun. 2011;408(1):12-17. doi:10.1016/j.bbrc.2011.03.089

GlyH-101 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.03mL

0.41mL

0.20mL

10.14mL

2.03mL

1.01mL

20.28mL

4.06mL

2.03mL

GlyH-101 技术信息

CAS号328541-79-3
分子式C19H15Br2N3O3
分子量 493.15
SMILES Code O=C(N/N=C/C1=CC(Br)=C(O)C(Br)=C1O)CNC2=CC=C3C=CC=CC3=C2
MDL No. MFCD01532954
别名 CFTR Inhibitor II; Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor II
运输蓝冰
InChI Key RMBDLOATEPYBSI-NUGSKGIGSA-N
Pubchem ID 135476586
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, sealed in dry, 2-8°C

溶解方案

DMSO: 55 mg/mL(111.53 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。